Literature DB >> 21900111

"Unfit" for Cisplatin: on basis of which GFR?

Omer Dizdar, Umut Demirci, Muhammet Fuat Ozcan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21900111     DOI： 10.1200/JCO.2011.37.6640

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  The method of GFR determination impacts the estimation of cisplatin eligibility in patients with advanced urothelial cancer.

Authors:  Thomas Horn; Barbara Ladwein; Tobias Maurer; Jutta Redlin; Anna Katharina Seitz; Jürgen E Gschwend; Margitta Retz; Hubert R Kübler
Journal:  World J Urol       Date:  2013-05-26       Impact factor: 4.226
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.